Canada Non Alcoholic Steatohepatitis (NASH) Therapeutics Market Analysis

Canada Non Alcoholic Steatohepatitis (NASH) Therapeutics Market Analysis

$ 3999

Canada Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. A number of factors, including the rising prevalence of non-alcoholic steatohepatitis, the rising incidence of chronic illnesses linked to it, the rising adoption of sedentary lifestyles, the rising awareness of health issues, etc., have contributed to the growth of the non-alcoholic steatohepatitis market over the past few years. Major global players in Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market are Intercept Pharmaceuticals, Inc. Novartis AG,Siemens Healthineers AG, AstraZeneca PLC, Galectin Therapeutics Inc., GENFIT S.A., Madrigal Pharmaceuticals, Inc., Inventiva S.A., ONE WAY LIVER, S.L., Galmed Pharmaceuticals Ltd., Cirius Therapeutics, Prometheus Laboratories Inc., BioPredictive.

ID: IN10CARD054 CATEGORY: Rare Diseases GEOGRAPHY: Canada AUTHOR: Gaurav Bhongale

Buy Now

Canada Non Alcoholic Steatohepatitis (NASH) Therapeutics Market Analysis Summary

Canada Non Alcoholic Steatohepatitis (NASH) Therapeutics Market is valued at around $90.4 Mn in 2022 and is projected to reach $1274.34 Mn by 2030, exhibiting a CAGR of 39.2% during the forecast period 2023-2030.

Non-alcoholic steatohepatitis (NASH), an inflammatory liver condition, is characterised by hepatocellular swelling, inflammation, and excessive fat deposition in the liver (steatosis). Non-Alcoholic Steatohepatitis, also referred to as "Silent Liver Disease," is a liver disease caused by chronic alcohol use, however, it primarily affects those who abstain from alcohol or only consume it in extremely small doses. Non-alcoholic steatohepatitis is the term for the second stage of non-alcoholic fatty liver disease (NAFLD), which has caused liver inflammation and cell death (NASH). The development of new pharmaceuticals, rising consumption of processed foods rich in fructose and polyunsaturated fatty acids, increased investment in medical infrastructure, and the proliferation of businesses offering non-invasive diagnostic methods are all expected to contribute to the market's expansion for Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market. Major global players in Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market are Intercept Pharmaceuticals, Inc. Novartis AG, Siemens Healthineers AG, AstraZeneca PLC, Galectin Therapeutics Inc., GENFIT S.A., Madrigal Pharmaceuticals, Inc., Inventiva S.A., ONE WAY LIVER, S.L., Galmed Pharmaceuticals Ltd., Cirius Therapeutics, Prometheus Laboratories Inc., BioPredictive.

Market Dynamics

Market Drivers

Along with cases of its associated chronic diseases, sedentary lifestyle adoption, greater health consciousness, and other factors, non-alcoholic steatohepatitis prevalence is rising. As a result, over the past few years, the non-alcoholic steatohepatitis market has been growing. If NASH is not treated, it can lead to cirrhosis and liver cancer. Chronic liver inflammation is a feature of NASH. Because they are more likely to have other symptoms (when two or more medical conditions are present), such as high blood pressure and coronary artery disease, patients with NASH are more likely to have a heart attack or stroke in addition to having an increased risk for liver-related illnesses. The non-alcoholic steatohepatitis market is developing internationally as a result of the rising number of NASH patients and the rising demand for NASH medications.

Market Restraints

The development of the market may be hampered by a lack of reliable and accessible diagnostic procedures, issues with regulatory compliance, and other considerations. NASH is now diagnosed via liver biopsies, imaging studies, and time-consuming, challenging diagnostic techniques such as blood testing. Due to the intrusive nature of liver biopsy, which entails high expenses, sampling errors, and considerable risks including bleeding, discomfort, perforation, infection, and even (rarely) death, many patients choose not to receive a diagnosis. In turn, this slows the rate of NASH diagnoses and limits the market's growth for non-alcoholic steatohepatitis worldwide.

Key players

Intercept Pharmaceuticals Inc Gilead Sciences Inc Galmed Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Stelara Therapeutics Inc Vivelix Inc Enanta Pharmaceuticals Inc Genfit SA Stealth Biotherapeutics Inc Wave Life Sciences Ltd

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For Canada Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market

By Drug Type

  • vitamin E
  • pioglitazone
  • ocaliva,
  • elafibranor
  • selonsertib
  • cenicriviroc
  • obeticholic
  • others

By Disease Cause

  • Hypertension
  • Heart Disease
  • High Blood Lipid
  • Type 2 Diabetes
  • Obesity

By Diagnostics:

  • Imaging Techniques
  • Diagnostic Tests
  • Biopsy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 04 July 2023
Updated by: Shivam Zalke

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter